SEC Filings for Kiniksa Pharmaceuticals Ltd. (KNSA)

$ 22.85   -0.20 (-0.87%) Volume: 171.17k 4:00 PM EDT Jul 7, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)307/07/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
4Statement of changes in beneficial ownership of securities107/02/2020
8-KCurrent report pursuant to Section 13 or 15(d)3106/29/2020
SC 13GStatement of acquisition of beneficial ownership by individuals806/16/2020
4Statement of changes in beneficial ownership of securities106/12/2020
S-3Registration statement under Securities Act of 19332605/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)4005/18/2020
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1005/18/2020
<<
First
<
Prev
123456789101112